Next Generation DNA Sequencing | Single Cell Technology

New mechanism that predicts a competitive advantage to SARS-CoV-2 virus carrying the D614G spike mutation

15 June 2020

A manuscript studying a prominent mutation in SARS-CoV-2 has been published on a preprint server by partners Single Cell Technology and Antibody Solutions.

Read More +

SCT to present candidate selection workflow at Antibody Engineering & Therapeutics

11 December 2019

SCT to present a candidate selection workflow of AbTheneum output at Antibody Engineering & Therapeutics using BCMA, TIGIT, and TIM3 to demonstrate the year-long effort. The presentation will be given on Wednesday, December 11 at the Marriott Marquis in San Diego…

Read More +

ACROBiosystems brings high affinity anti-BCMA antibodies, attending Fifteenth Annual PEGS Boston 2019

8 April 2019

ACROBiosystems, a leading manufacturer of recombinant proteins and critical reagents to the biopharma industry, today announced at the PEGS – Protein Engineering Summit the successful completion of isolation and characterization of a large panel of anti-human BCMA antibodies for the purpose of treating multiple myeloma cancer.

Read More +

SCT to present validated antibody leads against BCMA in a sponsored webinar

4 March 2019

Single Cell Technology is sponsoring a webinar hosted by Cambridge Healthtech Institute as a part of their sponsored webinar series. The webinar, titled, “AbTheneum Discovers Rare Hits and Delivers Antibody Metadata: Anti-BCMA Antibody Case Study,” will be presenting a number of antibody candidates discovered using SCT’s discovery platform.

Read More +

SCT to present at 2018 Antibody Engineering & Therapeutics Conference in San Diego

30 November 2018

San Jose, Calif. (Nov. 30, 2018) Single Cell Technology announced today that Chun-Nan Chen, Ph.D., CEO and CSO, will present at the 2018 Antibody Engineering & Therapeutics conference in San Diego, CA, December 10-13, 2018. Dr. Chen’s talk will present case studies and data output from…

Read More +

Single Cell Technology adds to international porfolio of patents

4 June 2018

Single Cell Technology has expanded its international patent portfolio, India Patent No. 296142 titled “Method of screening single cells for the production of biologically active agent” was issued on Apr. 25, 2018…

Read More +

Two additional US Patents issued for Single Cell Technology

9 July 2018

Single Cell Technology is proud to announce two new US patents issued, shoring up its intellectual property portfolio. US Patent No. 9,944,983, titled “Method of screening a plurality of single secreting cells for functional activity…

Read More +

SCT to present data at PEGS Boston 2018

23 April 2018

Single Cell Technology is to present a poster at PEGS Boston 2018 in Boston, MA, April 30-May 4, 2018. Allison Schulkins will be presenting a poster titled “A candidate triage roadmap: upfront affinity and cross-reactivity data dovetailed with sequence diversity and computational modeling reduce reconstruction workload.” “This poster really highlights the data output from AbTheneum, […]

Read More +

SCT NEWS

Press Releases

New mechanism that predicts a competitive advantage to SARS-CoV-2 virus carrying the D614G spike mutation

SCT to present candidate selection workflow at Antibody Engineering & Therapeutics

ACROBiosystems brings high affinity anti-BCMA antibodies, attending Fifteenth Annual PEGS Boston 2019

SCT to present validated antibody leads against BCMA in a sponsored webinar

SCT to present at 2018 Antibody Engineering & Therapeutics Conference in San Diego

Single Cell Technology adds to international porfolio of patents

Two additional US Patents issued for Single Cell Technology

SCT to present data at PEGS Boston 2018

Join the Single Cell
Technology Newsletter

Single Cell Technology - Newsletter

SCT NEWS

Press Releases

New mechanism that predicts a competitive advantage to SARS-CoV-2 virus carrying the D614G spike mutation

SCT to present candidate selection workflow at Antibody Engineering & Therapeutics

ACROBiosystems brings high affinity anti-BCMA antibodies, attending Fifteenth Annual PEGS Boston 2019

SCT to present validated antibody leads against BCMA in a sponsored webinar

SCT to present at 2018 Antibody Engineering & Therapeutics Conference in San Diego

Single Cell Technology adds to international porfolio of patents

Two additional US Patents issued for Single Cell Technology

SCT to present data at PEGS Boston 2018

Join the Single Cell Technology Newsletter

Single Cell Technology - Newsletter

Join the Single Cell
Technology Newsletter